Simplex Trading’s Profound Medical PROF Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$55.7K Buy
8,600
+8,500
+8,500% +$58.7K ﹤0.01% 5751
2025
Q4
$787 Sell
100
-6,000
-98% -$38.6K ﹤0.01% 8080
2025
Q3
$30K Buy
6,100
+100
+2% +$511 ﹤0.01% 6986
2025
Q2
$35K Hold
6,000
﹤0.01% 6271
2025
Q1
$34K Buy
+6,000
New +$41.4K ﹤0.01% 6140
2023
Q3
Sell
-100
Closed -$1K 9582
2023
Q2
$1K Buy
+100
New +$1.24K ﹤0.01% 8698
2022
Q4
Sell
-300
Closed -$1K 10159
2022
Q3
$1K Buy
+300
New +$2.02K ﹤0.01% 9609
2022
Q1
Sell
-700
Closed -$7K 11186
2021
Q4
$7K Buy
+700
New +$8.74K ﹤0.01% 9330
2021
Q2
Sell
-3
Closed -$6K 10568
2021
Q1
$6K Hold
3
﹤0.01% 8161
2020
Q4
$6K Buy
+3
New +$55 ﹤0.01% 7665

Other funds holding PROF

Simplex Trading's PROF Position: Q1 2026 in Review

Simplex Trading increased its Profound Medical (PROF) stake by 6,050% in Q1 2026, buying an estimated $250K and bringing the position to 36,718 shares worth $238K. The position accounts for ﹤0.01% of the portfolio, ranked #4087.

Simplex Trading first reported a position in PROF in Q1 2021 and has held it in 12 quarters since. 57 funds tracked by Wall St. Rank hold PROF as of Q1 2026.

  • Simplex Trading held 36,718 shares of Profound Medical worth $238K as of Q1 2026.
  • Simplex Trading bought 36,121 Profound Medical shares in Q1 2026, an estimated $250K.
  • Profound Medical made up ﹤0.01% of Simplex Trading's portfolio in Q1 2026, its #4087 holding.
  • Simplex Trading first reported a position in Profound Medical in Q1 2021 and has held it in 12 quarters since.
  • 57 funds tracked by Wall St. Rank held Profound Medical as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.